Mandolin is a San Francisco healthcare AI company building agents that handle the paperwork blocking patients from specialty drugs. Its software automates intake, benefits verification, prior authorization, and claims work for infusion providers, specialty pharmacies, and health systems - the back office that decides how quickly a cancer or Alzheimer's patient actually gets treated.
Float Health runs an on-demand marketplace that dispatches vetted registered nurses to patients' homes for specialty medication infusions. The San Francisco startup pairs an AI-powered scheduling platform with a gig-style nurse network, and acts as the staffing backbone for specialty pharmacies like CVS, Optum, Walgreens, Kroger and Option Care Health.
House Rx is a San Francisco-based healthcare technology company that partners with specialty clinics to enable medically integrated dispensing (MID) - a model where physicians, pharmacists, nurses, and care coordinators work together as one unified team. Founded in 2021 by Flatiron Health veterans Ogi Kavazovic and Tesh Khullar, the company builds AI-enabled pharmacy management software that keeps specialty medications dispensed at the point of care, cutting average time-to-therapy from 15.5 days to 3.5 days and achieving 95% medication adherence. With $100M raised across Seed, Series A, and Series B rounds, House Rx serves 80 clinic sites, 1,000+ providers, and nearly 61,000 patients, processing approximately $1.5 billion in specialty prescriptions annually.
Joy Liu is the co-founder and CEO of Plenful, a San Francisco-based AI workflow automation platform modernizing healthcare operations. A Northwestern-trained economist who cut her teeth at Goldman Sachs and Barclays before moving into specialty pharmacy operations at Shields Health Solutions, Liu built Plenful from first-hand frustration with manual pharmacy workflows. Since emerging from stealth in 2023, she has grown the company to 60+ healthcare customers, achieved 4x year-over-year growth, and raised $76 million in total funding - including a $50 million Series B in 2025 co-led by Danaher co-founder Mitchell Rales. Named to Inc.'s 2026 Female Founders 500 list, Liu is on a mission to return time and focus to healthcare workers drowning in administrative burden.
Ogi Kavazovic is the co-founder and CEO of House Rx, a San Francisco-based specialty pharmacy platform that enables clinical practices to dispense specialty medications directly to patients in-house. A serial operator who helped scale Opower (acquired by Oracle) and Flatiron Health (acquired by Roche), Ogi pivoted to fix a problem he kept seeing: patients leaving the doctor's office only to get lost in a broken specialty pharmacy system. House Rx has raised $100 million in total, including a $55 million Series B in November 2025, and now processes approximately $1.5 billion in specialty scripts annually across 80+ clinic sites.
Ryan Johnson is the Co-Founder and CEO of Float Health, a San Francisco-based healthtech company he founded in 2021 that connects specialty pharmacies and patients with vetted nurses for on-demand home infusion therapy. A former ER nurse with over 20 years of bedside and leadership experience across pre-hospital, rescue, and hospital settings, Ryan built Float after watching his own father depend on specialty infusions - care he could administer at home himself. Float graduated from Y Combinator's Winter 2022 batch and has raised $15 million in total funding, including a $10 million Series A led by Canvas Ventures in March 2024. The platform has completed over 86,000 home medication visits for clients including Optum, CVS, and Option Care Health.
Plenful is a San Francisco-based AI workflow automation company building software that takes the busywork out of pharmacy and healthcare operations. Founded in 2021 by former pharmacy operator Joy Liu, the company helps health systems, specialty pharmacies, and infusion teams automate 340B audits, rebate management, prior authorization, and patient intake - work that has long been trapped in PDFs, faxes, and spreadsheets.
Mike Fitzgibbons is the CEO and Founder of Claritas Rx, a South San Francisco-based healthtech company that uses AI and real-world patient-level data to help biopharmaceutical companies track, understand, and support patients across the specialty drug treatment journey. Founded in 2011, Claritas Rx serves 20+ rare and specialty therapeutic areas and has appeared on Inc.'s 2025 list of America's Fastest-Growing Private Companies. Before founding Claritas Rx, Fitzgibbons spent seven years at Morgan Stanley as an equity research analyst covering pharma services and drug distribution, then joined Genentech where he worked on pricing strategy and led the Avastin marketing team - experiences that directly shaped his conviction that patient-level data, not aggregated reports, is what biopharma companies actually need.